These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lanthanum carbonate: safety data after 10 years. Hutchison AJ, Wilson RJ, Garafola S, Copley JB. Nephrology (Carlton); 2016 Dec; 21(12):987-994. PubMed ID: 27479781 [Abstract] [Full Text] [Related]
3. [Introduction to lanthanum carbonate: pharmacology, safety and tolerability]. Rodríguez Portillo M. Nefrologia; 2008 Dec; 28 Suppl 5():7-10. PubMed ID: 18847413 [Abstract] [Full Text] [Related]
4. A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate. Sprague SM. Curr Med Res Opin; 2007 Dec; 23(12):3167-75. PubMed ID: 17991307 [Abstract] [Full Text] [Related]
6. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Lanthanum carbonate and new phosphate binders in patients with chronic kidney disease]. Negi S, Shigematsu T. Clin Calcium; 2010 Jul; 20(7):1096-102. PubMed ID: 20585189 [Abstract] [Full Text] [Related]
7. Lanthanum carbonate and peritoneal catheter dysfunction. Rodríguez-Palomares JR, de Arriba G, Gómez L, Pérez K, Basterrechea M, Hernández B, Tallón S. Nefrologia; 2012 May 14; 32(3):415-6. PubMed ID: 22592438 [No Abstract] [Full Text] [Related]
8. Does concomitant administration of sevelamer hydrochloride and lanthanum carbonate modify the control of phosphatemia? Senatore M, Coppolino G, Papalia T, Greco R, Lofaro D, Bonofiglio R. Eur Rev Med Pharmacol Sci; 2011 Nov 14; 15(11):1352-4. PubMed ID: 22195373 [No Abstract] [Full Text] [Related]
12. One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis. Shigematsu T, Lanthanum Carbonate Research Group. Ther Apher Dial; 2010 Feb 14; 14(1):12-9. PubMed ID: 20438515 [Abstract] [Full Text] [Related]
13. Clinical usefulness of lanthanum carbonate for serum phosphate control in difficult patients. Almirall J, Betancourt L, Esteve V, Valenzuela MP, López T, Ruiz A, Martínez-Ocaña JC, Calvet X. Int Urol Nephrol; 2012 Feb 14; 44(1):231-6. PubMed ID: 21069570 [Abstract] [Full Text] [Related]
14. Pharmacology of the phosphate binder, lanthanum carbonate. Damment SJ. Ren Fail; 2011 Feb 14; 33(2):217-24. PubMed ID: 21332344 [Abstract] [Full Text] [Related]
16. Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study. Martin P, Wang P, Robinson A, Poole L, Dragone J, Smyth M, Pratt R. Am J Kidney Dis; 2011 May 14; 57(5):700-6. PubMed ID: 21354682 [Abstract] [Full Text] [Related]
18. Lanthanum carbonate as a first-line phosphate binder: the "cons". Drüeke TB. Semin Dial; 2007 May 14; 20(4):329-32. PubMed ID: 17635823 [Abstract] [Full Text] [Related]
19. Lanthanum carbonate--a first line phosphate binder? de Freitas D, Donne RL, Hutchison AJ. Semin Dial; 2007 May 14; 20(4):325-8. PubMed ID: 17635822 [Abstract] [Full Text] [Related]